Table 4.

Ethics of Psychiatric Surgery SWOT

Strengths	Weaknesses
Other indications (e.g. movement disorders) have paved the way for neuromodulation for psychiatric disease	Limited study of the ethics of neuromodulation for psychiatric disease Limited access of patients to trials/therapies Treatment resistant patients are desperate for novel therapies making informed consent difficult
Opportunities	Threats
Studies of DBS for psychiatric disorders may contribute to our broader understanding of these diseases Focus on development of trials with not (merely) for patients Advocate for new laws regarding psychiatric surgery	Public misunderstanding of a novel therapy or stigma associated with treatment Some patient populations may be averse to new therapies due to mistrust There are laws in place that prohibit or limit eligibility for psychiatric surgery in some areas of the world